Skip to content

Cohort for biomarkers to predict prognosis and treatment response in acute leukemia

Cohort for biomarkers to predict prognosis and treatment response in acute leukemia

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0002261
Enrollment
1500
Registered
2017-03-10
Start date
2016-07-08
Completion date
Unknown
Last updated
2020-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

The Catholic University of Korea, Seoul St. Mary's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) patient group ? step 1: adult with over 18-year-old, patients who confirmed of acute leukemia by WHO classification, patients who can be checked the electronic medical record ? step 2: adult with over 18-year-old, patients who suspected of acute leukemiaL, and then confirmed with bone marrow apsirate by WHO classification, Patients with voluntary informed consent about blood and bone marrow sampling. 2) healthy donor group : among the all hematopoietic stem cell donors, healthy donor who donated with bone marrow cells

Exclusion criteria

Exclusion criteria: patients who not finally confirmed of acute leukemia by WHO classification

Design outcomes

Primary

MeasureTime frame
Characteristics of patient and leukemia at diagnosis, type of chemotherapy, chemotherapy response, hematopoietic stem cell transplantation and related-survival rate, incidence of HSCT-related complications

Secondary

MeasureTime frame
Promising biomarker determination

Countries

Korea, Republic of

Contacts

Public ContactByung-Sik Cho

The Catholic University of Korea

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 17, 2026